Royal Papworth Hospital NHS Foundation Trust | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder	Active, not recruiting	Phase 3	2026-10-09		NCT05444257
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)	lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder	Recruiting	Phase 3	2026-07-29		NCT06274801
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG	Arrhythmias, Cardiac, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, nervous system disorder, stroke disorder, vascular disorder	Recruiting	Phase 3	2026-06-26		NCT04045665
iCorMicA - Stratified Medicine in Angina	Angina Pectoris, Angina, Stable, Arterial Occlusive Diseases, Chest Pain, Microvascular Angina, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Prinzmetal angina, Signs and Symptoms, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, intermediate coronary syndrome, ischemic disease, myocardial ischemia, vascular disorder	Recruiting	Not applicable	2026-04-09		NCT04674449